Comparison

Tizanidine hydrochloride European Partner

Item no. HY-B0194A-50mg
Manufacturer MedChem Express
CASRN 64461-82-1
Amount 50 mg
Category
Type Inhibitors
Purity 99.67
Formula C9H9Cl2N5S
Citations [1]Kamen L, et al. A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury. Curr Med Res Opin. 2008 Feb;24(2):425-39.
Smiles ClC1=C(NC2=NCCN2)C3=NSN=C3C=C1.Cl
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias 64461-82-1
Available
StorageTemperature
4°C (Powder, sealed storage, away from moisture)
Shipping
Room Temperature
Manufacturers Applications
Neuroscience-Neuromodulation
Molecular Weight
290.17
Clinical Information
Launched
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)|H2O : 20 mg/mL (ultrasonic)
Isoform
α adrenergic receptor
Pathway
GPCR/G Protein; Neuronal Signaling
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close